Suggestions

Du même auteur

Genomics to select treatment for patients with metastatic breast cancer

Archive ouverte | Andre, Fabrice | CCSD

International audience

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Archive ouverte | Bachelot, Thomas | CCSD

International audience

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Archive ouverte | Bachelot, Thomas | CCSD

International audience. PURPOSE Everolimus, an oral inhibitor of the mammalian target of rapamycin, improves progression-free survival in combination with endocrine therapy (ET) in postmenopausal women with aromatas...

Chargement des enrichissements...